Title: Fabrice Sircoulomb: Innovator in Breast Cancer Diagnosis
Introduction
Fabrice Sircoulomb is an inventor based in Toronto, Canada. He has made significant contributions to the field of medical research, particularly in the diagnosis of breast cancer. Although he currently holds no granted patents, his work is noteworthy for its potential impact on healthcare.
Latest Patent Applications
Fabrice Sircoulomb's notable patent application is titled "Marker of Breast Tumors from the Luminal-B Subtype." This application describes an in vitro method for diagnosing breast cancer from the luminal-B subtype in females. The method includes analyzing a biological sample by determining the copy number and expression of the ZNF703 gene. An increased copy number or over-expression of this gene is indicative of a luminal B tumor. The application also details a kit for diagnosing this subtype, which includes nucleic acid probes or antibodies for determining the gene's copy number and expression.
Conclusion
Fabrice Sircoulomb's innovative approach to breast cancer diagnosis highlights the importance of research in medical science. His work has the potential to improve diagnostic methods and patient outcomes in the future.